Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (2.312)

2024

  1. A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

    Clinical Cancer Research, Vol. 30, Núm. 4, pp. 695-702

  2. A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration–Resistant Prostate Cancer: Results from CYCLONE 1

    Clinical Cancer Research, Vol. 30, Núm. 11, pp. 2377-2383

  3. A Validated Highly Sensitive Microsatellite Instability Assay Accurately Identifies Individuals Harboring Biallelic Germline PMS2 Pathogenic Variants in Constitutional Mismatch Repair Deficiency

    Clinical chemistry, Vol. 70, Núm. 5, pp. 737-746

  4. A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results

    Annals of Oncology, Vol. 35, Núm. 8, pp. 707-717

  5. A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24

    BJU International

  6. A retrospective study of do-not-do practice recommendations in metastatic breast cancer in Spain

    Revista de Senologia y Patologia Mamaria, Vol. 37, Núm. 3

  7. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

    Blood, Vol. 143, Núm. 18, pp. 1807-1815

  8. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  9. Adaptation and validation of the Physical Restraint-Theory of Planned Behaviour Questionnaire to the paediatric context

    Nursing in Critical Care, Vol. 29, Núm. 5, pp. 1086-1099

  10. Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

    Journal of the American Heart Association, Vol. 13, Núm. 4, pp. e030623

  11. Analysis of the reasons for requesting HIV serology in the emergency department other than those defined in the targeted screening strategy of the “Urgències VIHgila” program and its potential inclusion in a future consensus document

    Enfermedades Infecciosas y Microbiologia Clinica

  12. Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO

    Transplantation and Cellular Therapy

  13. Asociación Española de Neurogastroenterología y Motilidad (ASENEM) updated review on the management of functional abdominal pain

    Gastroenterologia y Hepatologia

  14. Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor

    Clinical Genitourinary Cancer, Vol. 22, Núm. 6

  15. At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods

    Scientific Reports, Vol. 14, Núm. 1

  16. Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial

    Circulation, Vol. 149, Núm. 25, pp. 1938-1948

  17. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

    Lung Cancer, Vol. 194

  18. Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study

    Journal of Thoracic Oncology, Vol. 19, Núm. 2, pp. 285-296

  19. Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real-world setting

    HemaSphere, Vol. 8, Núm. 7

  20. Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment

    Biomedicine and Pharmacotherapy, Vol. 173